ÖÐÄÏ´óѧ¹ú¼ÒÏîÄ¿JBCÉñ¾Ñ§Ñо¿³É¹û
ÅÁ½ðÉÖ¢£¨pD£©ÊÇ×î³£¼ûµÄÄêÁäÏà¹ØÐÔÉñ¾ÍËÐÐÐÔÔ˶¯Õϰ¡£Ô½À´Ô½¶àµÄÖ¤¾Ý±íÃ÷£¬»·¾³ºÍÒÅ´«ÒòËØÔÚÅÁ½ðÉÖ¢µÄ·¢²¡»úÖÆÖаçÑÝ×ÅÖØÒªµÄ½ÇÉ«£¬µ«ÊÇ£¬ÔÚÅÁ½ðÉÖ¢²¡ÒòÖУ¬»·¾³ºÍÒÅ´«Ñ§Ö®¼äµÄDZÔÚÏ໥×÷Óã¬Ôںܴó³Ì¶ÈÉÏÈÔÈ»ÊÇÄÑÒÔ×½ÃþµÄ¡£ÑÓÉìÔĶÁ£º±û¸Î»áÔö¼ÓÅÁ½ðÉÖ¢·çÏÕ£¿£¡¡£
×î½ü£¬ÃÀ¹úSanford-BurnhamҽѧÑо¿ËùºÍÖÐÄÏ´óѧµÄÑо¿ÈËÔ±ÔÚ¹ú¼ÊÖøÃûѧÊõÆÚ¿¯¡¶Journal of Biological Chemistry¡··¢±íÌâΪ¡°Regulation of Histone Acetylation by Autophagy in parkinson Disease¡±µÄÑо¿³É¹û¡£ÕâÏîÑо¿±íÃ÷£¬ÅÁ½ðÉÖ¢Ïà¹ØµÄ»·¾³¶¾Ëؿɵ÷½Ú×ÔÊɲúÉúµÄ×éµ°°×ÒÒõ£»¯Òì³££¬´Ó¶øÓÐÖúÓÚÅÁ½ðÉÖ¢µÄ·¢²¡»úÖÆ¡£
ÕâÏîÑо¿µÄͨѶ×÷ÕßÊÇÖÐÄÏ´óѧ¸±Ð£³¤ÕÅׯ»ª½ÌÊÚ£¬ÕŽÌÊÚ1986Äê7ÔÂÖÁ1989Äê7ÔºþÄÏÒ½¿Æ´óѧҽѧÒÅ´«Ñ§×¨ÒµË¶Ê¿Ñо¿Éúѧϰ£»1991Äê7ÔÂÖÁ1995Äê7ÔÂÃÀ¹ú¼ÓÖÝ´óѧʥµØÑǸç·ÖУ·Ö×Ó²¡Àíѧרҵ²©Ê¿Ñо¿Éúѧϰ£»1995Äê8ÔÂÖÁ1996Äê7ÔÂÔÚÃÀ¹úLa Jolla°©Ö¢Ñо¿Ëù×ö·Ö×ÓÓëϸ°ûÉúÎïѧ²©Ê¿ºóÑо¿¡£1996Äê7Ô½úÉý¸±½ÌÊÚ£¬1998Äê12Ô½úÉý½ÌÊÚ£¬2001ÄêÆ¸Îª****ÌØÆ¸½ÌÊÚ£¬2008ÄêÈëÑ¡¹ú¼ÒÊ×Åú¡°****¡±¡£1998Äê12ÔÂÈκþÄÏÒ½¿Æ´óѧҽѧÒÅ´«Ñ§¹ú¼ÒÖØµãʵÑéÊÒ½ÌÊÚ£¬¸±Ö÷ÈÎ(¼æ)£¬2003Äê3ÔÂÖÁ2006Äê12ÔÂÈÎÖÐÄÏ´óѧҽѧÒÅ´«Ñ§¹ú¼ÒÖØµãʵÑéÊÒ½ÌÊÚ£¬Ö÷ÈΣ¨¼æ£©£¬2007Äê1ÔÂÈÎÖÐÄÏ´óѧҽѧÒÅ´«Ñ§¹ú¼ÒÖØµãʵÑéÊÒÖ÷ÈΣ¬2008Äê9ÔÂÈÎÖÐÄÏ´óѧУ³¤ÖúÀí£¬2010Äê12ÔÂÈÎÖÐÄÏ´óѧ¸±Ð£³¤¡£Ö÷Òª´ÓÊÂÖÐÊàÉñ¾ÏµÍ³µÄ·Ö×ÓÓëϸ°ûÉúÎïѧºÍÉñ¾ÍËÐÐÐÔ¼²²¡µÄ·Ö×Ó²¡Àí»úÖÆÑо¿£¬ÔÚ¶àÖÖ¹ú¼ÊÖøÃûѧÊõ¿¯ÎïÉÏ·¢±íÑо¿ÂÛÎÄ40¶àƪ£¬ËûµÄÑо¿±»Í¬ÐÐÒýÓó¬¹ý3500´Î¡£
ÖÚËùÖÜÖª£¬»·¾³ÒòËØÔÚÅÁ½ðɲ¡ÖÐÆðÖØÒª×÷ÓᣳýÁËË¥ÀÏÖ®Í⣬±©Â¶ÓÚ»·¾³¶¾ËØ£¬ÈçijЩɱ³æ¼ÁºÍ³ý²Ý¼Á£¬¿Éµ¼ÖÂÀàËÆÓÚÔ·¢ÐÔÅÁ½ðɲ¡µÄÅÁ½ðÉÖ¢¡£Òò´Ë£¬ÒÅ´«ÒòËØºÍ»·¾³ÒòËØ¶¼ÓÐÖúÓÚÅÁ½ðɲ¡µÄ·¢²¡»úÖÆ¡£È»¶ø£¬»·¾³ÒòËØÓÕ·¢µÄÅÁ½ðÉÖ¢µÄ·Ö×Ó»ù´¡£¬ÈÔ²»Ã÷È·¡£»·¾³ÒòËØÒÑÖªÒýÆðһЩ±í¹ÛÒÅ´«Ñ§ÐÞÊΣ¬´Ó¶øµ¼ÖÂÈËÀ༲²¡£¬°üÀ¨Éñ¾ÍËÐÐÐÔ¼²²¡¡£
Ãâ·ÑË÷È¡Bio-Rad΢µÎʽÊý×ÖpCRµÄ×îÐÂ×ÊÁÏ
ÕâÖÖÐÞÊÎͨ¹ý³ýDNAÐòÁиıäÖ®ÍâµÄ»úÖÆ£¬µ÷¿Ø×Å»ùÒò±í´ï¡£ÕâЩÀàÐ͵ĵ÷¿ØÊÇ¿ÉÒÅ´«µÄ¡¢ÄÜʹ×ÔÉíÓÀ¾Ã´æÔڵĺͿÉÄæµÄ¡£Ñо¿×î¶àµÄ±í¹ÛÒÅ´«Ñ§µ÷¿Ø°üÀ¨DNA¼×»ù»¯¡¢RNAÐÞÊκÍ×éµ°°×ÐÞÊΡ£
ÓëȾɫÖÊÏà¹ØµÄ×éµ°°×ÒÒõ£»¯£¬ÔÚϸ°û£¨°üÀ¨Éñ¾Ôª£©ÄÚת¼ÒÔ¼°ÆäËû¹¦Äܵıí¹ÛÒÅ´«µ÷½ÚÖУ¬ÆðמÙ×ãÇáÖØµÄ×÷Óá£ÔÚ¶¯ÎïÄ£ÐÍÖУ¬¼õÉÙµÄ×éµ°°×ÒÒõ£»¯ÒѾÔÚÉñ¾ÍËÐÐÐÔ¼²²¡ÖÐÓÐËù±¨µÀ£¬ÕâÖÖ¼²²¡µÄÌØÕ÷ÊÇÈÏÖªÄÜÁ¦Ï½µ£¬°üÀ¨°¢¶û´Äº£Ä¬Êϲ¡¡£
ÓÐÑо¿ÔÚÅÁ½ðÉ֢ģÐÍÖб¨µÀ¹ýÀàËÆµÄ½á¹û¡£±ûÎìËᡪ¡ªÒ»ÖÖ×éµ°°×ÍÑÒÒõ£Ã¸ÒÖÖÆ¼Á£¬ÔÚÅÁ½ðÉÖ¢´óÊóÄ£ÐÍÖбíÏÖ³ö¶ÔÓãÌÙͪµÄ·À»¤×÷Óá£ÔÚÌåÍâϸ°ûÅàÑøÎïºÍÌåÄÚ¹ûÓ¬ÅÁ½ðÉ֢ģÐÍÖУ¬È¥ÒÒõ£»¯Ã¸-2µÄÒÖÖÆ¼Á¿ÉÐÞ¸´Í»´¥ºËµ°°×£¨alphasynuclein£©½éµ¼µÄÉñ¾¶¾ÐÔ¡£ÕâЩ½á¹û±íÃ÷£¬×éµ°°×»ò·Ç×éµ°°×ÒÒõ£»¯×÷Óõĵ÷½ÚÒì³££¬ÊDz»Í¬Éñ¾ÍËÐÐÐÔ¼²²¡ÖÐÉñ¾±äÐԵĹ²Í¬»úÖÆ¡£
ÔÚÕâÏîÑо¿ÖУ¬Ñо¿ÈËÔ±Ö¼ÔÚ̽ÌÖ×éµ°°×ÒÒõ£»¯ÔÚÅÁ½ðÉÖ¢·¢²¡»úÖÆÖÐËùÆðµÄ×÷Óá£ÕâЩÑо¿½á¹û±íÃ÷£¬ÔÚÅÁ½ðÉÖ¢Ïà¹ØÉñ¾¶¾ËØ´¦Àí¹ýµÄϸ°ûÖУ¬ÒÔ¼°×¢ÉäMpTpµÄСÊó´óÄÔÖУ¬×éµ°°×ºÍ×éµ°°×ÒÒõ£»¯µÄˮƽÊÇÉϵ÷µÄ¡£Ñо¿ÈËÔ±ÔÚÅÁ½ðÉÖ¢»¼ÕßµÄÖÐÄÔDAÉñ¾ÔªÖУ¬Ò²¹Û²ìµ½ÁË×éµ°°×ÒÒõ£»¯Ë®Æ½µÄÉý¸ß¡£½øÒ»²½µÄ·ÖÎö±íÃ÷£¬HDACsµÄ±í´ï¼õÉÙ£¬¿ÉÄÜ»áʹÅÁ½ðÉÖ¢Ïà¹ØÉñ¾¶¾ËØÓÕµ¼µÄ×éµ°°×ÒÒõ£»¯·¢Éú±ä»¯¡£´ËÍ⣬ÒÖÖÆ×ÔÊÉ£¬¿ÉÒÖÖÆMpp+-ÓÕµ¼µÄHDACs½µ½â¡£ÕâЩÑо¿½á¹û±íÃ÷£¬ÅÁ½ðÉÖ¢Ïà¹ØµÄ»·¾³¶¾Ëؿɵ÷½Ú×ÔÊɲúÉúµÄ×éµ°°×ÒÒõ£»¯Òì³££¬´Ó¶øÓÐÖúÓÚÅÁ½ðÉÖ¢µÄ·¢²¡»úÖÆ¡£
£¨ÉúÎïͨ£ºÍõÓ¢£©
ÉúÎïÍ¨ÍÆ¼öÔÎÄÕªÒª£º
Regulation of Histone Acetylation by Autophagy in parkinson Disease
Abstract£ºparkinson disease (pD) is the most common age-dependent neurodegenerative movement disorder. Accumulated evidence indicates both environmental and genetic factors play important roles in pD pathogenesis, but the potential interaction between environment and genetics in pD etiology remains largely elusive. Here, we report that pD related neurotoxins induce both expression and acetylation of multiple sites of histones in cultured human cells and mouse midbrain dopaminergic (DA) neurons. Consistently, levels of histone acetylation are markedly higher in midbrain DA neurons of pD patients comparing to those of their matched control individuals. Further analysis reveals that multiple histone deacetylases (HDACs) are concurrently decreased in Mpp+-treated cells and MpTp-treated mouse brains, as well as midbrain tissues of human pD patients. Finally, inhibition of histone acetyltransferase (HAT) protects, while inhibition of HDAC1 and HDAC2 potentiates, Mpp+-induced cell death. pharmacological and genetic inhibition of autophagy suppresses Mpp+-induced HDACs degradation. The study reveals that pD environmental factors induce HDACs degradation and histone acetylation increase in DA neurons via autophagy and identifies an epigenetic mechanism in pD pathogenesis.